跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A·V·I NAD+ - TGA Drug Approval Details
Approvals
/
TGA
/
A·V·I NAD+
Approved
STANDARD
A·V·I NAD+
ALSL Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
bbcf23fb780bbdc8
Company
ALSL Pty Ltd
Type
Standard
Approval Details
Approval Id
bbcf23fb780bbdc8
Product Name
A·V·I NAD+
Artg Id
378148
Artg Name
A·V·I NAD+
Sponsor
ALSL Pty Ltd
Company Detail Path
/organization/alsl-pty-ltd
Artg Date
2021-11-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
bbcf23fb780bbdc8
Type
Standard
Back to TGA Approvals